The disruption to biopharma and medtech businesses caused by Covid-19, from sales rep visits with doctors, product launch and clinical trial delays has underscored the need for a more digital focused strategy.
Covid-19’s digital imperative for biopharma and medtech
No Comments
Previous Post
Algorithm that predicts Covid-19 complications gets EUA
Next Post
Medicare to cover all FDA-approved Covid-19 vaccines
Recent Posts
- Gilead’s cell therapy Yescarta awarded FDA approval for follicular lymphoma 08/03/2021
- FDA approval brings remote programming for Abbott’s deep brain stimulation device 08/03/2021
- Beckman Coulter seeks authorization for $4 antigen test 28/01/2021
- 3 tech-driven innovative patient engagement strategies transforming healthcare today 09/12/2020
- Lucira Covid-19 test is first to get FDA nod for home use 19/11/2020
Categories
- Coding (3)
- news (17)
- Photography (3)
- Social Marketing (3)
- uncategorized (1)
- WordPress (4)